Calidi Biotherapeutics CLDI
NYSE CLDI
$1.07 +0.01 (+0.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Calidi Biotherapeutics (CLDI) Other Accumulated Expenses (2022 - 2024)

Updated

Calidi Biotherapeutics (CLDI) reported Other Accumulated Expenses of $638,000 for Q4 2024, up 2.9% from the prior quarter.

Analysis

Calidi Biotherapeutics (CLDI) Other Accumulated Expenses (2022 - 2024) Analysis & Trends

Dating back to Q4 2022, Calidi Biotherapeutics' Other Accumulated Expenses record includes 7 quarters.

  • By year, Other Accumulated Expenses came in at $7,719 in FY2022.
  • Per Business Quant data, the three quarters before Q4 2024 came in at $620,000 (Q3 2024), $597,000 (Q2 2024) and $567,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Calidi Biotherapeutics 1.52 Mn -23.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 638,000.00
Sep 30, 2024 620,000.00
Jun 30, 2024 597,000.00
Mar 31, 2024 567,000.00
Jun 30, 2023 143,589.00
Mar 31, 2023 73,158.00
Dec 31, 2022 7,719.00
API Access

Calidi Biotherapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEY